# Nuclide record jonathan-strosberg (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/jonathan-strosberg/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "jonathan-strosberg" ;
  schema:name "Jonathan R. Strosberg"@en ;
  schema:description "Led NETTER-1, the trial that made lutetium dotatate the first approved radioligand therapy for neuroendocrine tumours."@en ;
  schema:url <https://nuclide.cc/people/jonathan-strosberg/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Strosberg%20J%5BAuthor%5D%20neuroendocrine%20lutetium> ;
  nuclide:tag "neuroendocrine", "radioligand", "trialist" ;
  schema:jobTitle "Section Head, Neuroendocrine Tumor Program, Moffitt Cancer Center" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/sstr2/> ;
  nuclide:drugs <https://nuclide.cc/drugs/lutathera/> ;
  nuclide:trials <https://nuclide.cc/trials/compete/> ;
  nuclide:keyPapers <https://nuclide.cc/key-papers/paper-netter-2-lancet-2024/> .